Regenerative Medicine Global Market Trends

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential

Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 145 pages

Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Antibacterials Market to 2017 - Innovative Anti-Infectives that Target ...

Industries: Therapy | Countries: World

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 140 pages

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications Summary GBI Research's new report, ?Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease ...

Industries: Therapy | Countries: World

Anavex Life Sciences Corp. - Product Pipeline Review - 2012

Anavex Life Sciences Corp. - Product Pipeline Review - 2012

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 54 pages

Anavex Life Sciences Corp. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Anavex Life Sciences Corp. - Product Pipeline Review - 2012? provides data on the Anavex Life Sciences Corp.'s research and development focus. The report includes information on current ...

Industries: Therapy | Countries: World

Drug Discovery and Development in United States: Bionovo, Inc. ? Product Pipeline Review - H2 2011

Drug Discovery and Development in United States: Bionovo, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 68 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the Bionovo, Inc.?s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data ...

Industries: Therapy | Countries: World

Drug and Medication in United States: CSL Limited - Product Pipeline Review - H2 2011

Drug and Medication in United States: CSL Limited - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 104 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, CSL Limited's corporate website, SEC filings, investo ...

Industries: Therapy | Countries: United States, World

Drug Discovery and Development in Russian Federation: CEL-SCI Corporation - Product Pipeline Review - H2 2011

Drug Discovery and Development in Russian Federation: CEL-SCI Corporation - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 82 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, CEL-SCI Corporation's corporate website, SEC filings, ...

Industries: Therapy | Countries: World, United States

Pharmaceutical in Canada: Galderma S.A. ? Product Pipeline Review - H2 2011

Pharmaceutical in Canada: Galderma S.A. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 69 pages

. - Product Pipeline Review - H2 2011? provides a detailed overview on the Galderma S.A.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information ...

Industries: Therapy | Countries: World

Pharmaceutical in United States: Hospira, Inc. ? Product Pipeline Review - H2 2011

Pharmaceutical in United States: Hospira, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 111 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the Hospira, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information ...

Industries: Therapy | Countries: United States, World, Australia

Pathology in United States: LEO Pharma A/S - Product Pipeline Review - H2 2011

Pathology in United States: LEO Pharma A/S - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 100 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, LEO Pharma A/S's corporate website, SEC filings, ...

Industries: Therapy | Countries: United States, World

Drug Discovery and Development in United States: Kuros Biosurgery AG - Product Pipeline Review - H2 2011

Drug Discovery and Development in United States: Kuros Biosurgery AG - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 44 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, Kuros Biosurgery AG's corporate website, SEC filings, ...

Industries: Therapy | Countries: United States, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • 00 1 718 618 48 97

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.